User profiles for Andrew Cope

Andrew Cope

Professor of Rheumatology, King's College London
Verified email at kcl.ac.uk
Cited by 15304

[HTML][HTML] Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence

…, C Moss, G George, A Santaolalla, A Cope… - …, 2020 - ncbi.nlm.nih.gov
Background Cancer and transplant patients with COVID-19 have a higher risk of developing
severe and even fatal respiratory diseases, especially as they may be treated with immune-…

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid …

…, C Gabay, AI Catrina, AP Cope… - Annals of the …, 2012 - ard.bmj.com
The Study Group for Risk Factors for Rheumatoid Arthritis was established by the EULAR
Standing Committee on Investigative Rheumatology to facilitate research into the preclinical …

[PDF][PDF] Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation

…, S Meri, TP Arstila, PT Pekkarinen, M Ma, A Cope… - Immunity, 2013 - cell.com
Complement is viewed as a critical serum-operative component of innate immunity, with
processing of its key component, C3, into activation fragments C3a and C3b confined to the …

T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells

…, MA Cooper, M Arno, B Afzali, HJ Lachmann, AP Cope… - Science, 2016 - science.org
INTRODUCTION The inflammasomes and the complement system are traditionally viewed
as quintessential components of innate immunity required for the detection and elimination of …

[PDF][PDF] The central role of T cells in rheumatoid arthritis

AP Cope, H Schulze-Koops… - Clinical and experimental …, 2007 - researchgate.net
Rheumatoid arthritis (RA) is one of the most common chronic inflammatory syndromes. As
such, RA is often considered the prototype disease for defining both the molecular and …

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

AP Cope, D Gibbons, FM Brennan… - … : Official Journal of …, 1992 - Wiley Online Library
Objective. Recently, 2 classes of cytokine inhibitors have been defined at the molecular level.
The largest group comprises the extracellular domains of cell surface cytokine receptors, …

Treg cells suppress osteoclast formation: a new link between the immune system and bone

…, H Schulze‐Koops, N Horwood, A Cope… - … : Official Journal of …, 2007 - Wiley Online Library
Objective To investigate whether Treg cells can suppress osteoclast differentiation, and to
define a new potential link between the immune system and the skeleton. Methods Regulatory …

[HTML][HTML] The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study

…, D Baudry, MA Brown, AP Cope… - The Lancet …, 2021 - thelancet.com
Background Patients on therapeutic immunosuppressants for immune-mediated inflammatory
diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate …

Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells

…, T Suddason, G Lord, JP Atkinson, A Cope… - Nature …, 2010 - nature.com
In this study we demonstrate a new form of immunoregulation: engagement on CD4 + T cells
of the complement regulator CD46 promoted the effector potential of T helper type 1 cells (T …

The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells

S Jones, N Horwood, A Cope, F Dazzi - The Journal of Immunology, 2007 - journals.aai.org
Although it has been widely demonstrated that human mesenchymal stem cells exert potent
immunosuppressive effects, there is little information as to whether more mature …